Moderna said in a statement Thursday that it plans to "vigorously defend" against other companies' attempts to claim credit and that its vaccine is a product of years of work on its own mRNA platform.
March 17, 2022 at 05:00 PM
3 minute read
Another biopharmaceutical company claims it should be compensated for its patented delivery particles being used in COVID vaccines.
Massachusetts based Alnylam Pharmaceuticals Inc. filed claims in the District of Delaware Thursday against Pfizer, its subsidiary Pharmacia & Upjohn Co. and Moderna, marking the second time in less than a month the court has seen a case alleging patent infringement by a major vaccine producer.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Photo credit: Trsakaoe – stock.adobe.com
